Oncología ginecológica y peritoneal

(JIF 2024)

-Bebia V, Díaz B, Tejerizo A, Torne A, Benito V, Hernández A, Gorostidi M, Domingo S, Bradbury M, Luna R, Gil A, SPAIN G. Patterns of First Recurrence and Oncological Outcomes in Locally Advanced Cervical Cancer Patients: Does Surgical Staging Play a Role?. Cancers. 2024; 16(7):1423. DOI:10.3390/cancers16071423. PMID:38611101. IF:4,400 (Q2/3D). Document type: Article.

-Gavira J, Tapia JC, Romano A, Anguera G, Aguado M, Piedra A, Bosma F, Sánchez S, Martin C, Algaba F, Arce Y, Cajal TRY, Maroto P. Challenges of diagnosing homologous recombination deficiencies in metastatic prostate cancer: a six-year experience from a single institution. Clinical & Translational Oncology. 2024; 26(10). DOI:10.1007/s12094-024-03483-8. PMID:38722534. IF:2,500 (Q3/6D). Document type: Article.

-Perez JA, Gálvez F, Guerra EM, Madariaga A, Manzano A, Martin C, Rubio MJ, Alarcón J, Barretina MP, Gaba L. SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023). Clinical & Translational Oncology. 2024; 26(11). DOI:10.1007/s12094-024-03531-3. PMID:39008159. IF:2,500 (Q3/6D). Document type: Article.

-RAMON N, Mereu L, Planchamp F, Falconer H, El A, Barahona M, Fagotti A, Querleu D, Taskiran C. ESGE/ESGO/SERGS consensus statement on surgical steps in minimally invasive surgery in gynecologic oncology: transperitoneal and extraperitioneal approach for paraaortic lymphadenectomy. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2024; DOI:10.1136/ijgc-2024-005796. PMID:39317443. IF:4,700 (Q1/1D). Document type: Article.

-Tapia JC, Bosma F, Gavira J, Sanchez S, Molina MA, Sanz J, Martin C, Anguera G, Maroto P. Treatment Patterns and Survival Outcomes Before and After Access to Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma: A Single-Center Retrospective Study From 2004 to 2021. Clinical Genitourinary Cancer. 2024; 22(3):102047. DOI:10.1016/j.clgc.2024.01.019. PMID:38430859. IF:2,700 (Q2/3D). Document type: Article.

-Tapia JC, Gavira J, Anguera G, Sanchez S, Romano A, Bosma F, Molina A, Sanz J, Martin C, Algaba F, Maroto P. Cumulative incidences of hypogonadism, hypertension, and dyslipidaemia in patients with stage I seminoma treated with a risk-adapted strategy: a Spanish single-centre retrospective analysis. Clinical & Translational Oncology. 2024; 26(7). DOI:10.1007/s12094-024-03393-9. PMID:38421563. IF:2,500 (Q3/6D). Document type: Article.

(JIF 2023)

-Cueva JF, Palacio I, Churruca C, Herrero A, Pardo B, Constenla M, Santaballa A, Manso L, Estévez P, Maximiano C, Legerén M, Marquina G, de Juan A, Quindós M, Sánchez L, Barquin A, Fernández I, Martín C, Juárez A, Martín T, García Y, Yubero A, Gallego A, Martínez Bueno A, Guerra E, González-Martín A. Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme. Eur J Cancer. 2023; Mar;182:3-14. DOI: 10.1016/j.ejca.2022.12.023. PMID:36706655. IF:7,600 (Q1/2D). Document type: Article.

-Espanol P, RAMON N, Caruana P, Luna R, Soler C, Teixeira N, Rodriguez F, Gallardo A, Edwards M, Porta O, Gamez M, Sanchez O, Llurba E, Corchero JL, Cespedes MV. Dopamine receptors D1 and D2 show prognostic significance and potential therapeutic applications for endometrial cancer patients. GYNECOLOGIC ONCOLOGY. 2023; 176. DOI:10.1016/j.ygyno.2023.06.019. PMID:37437489. IF:4,500 (Q1/1D). Document type: Article.

-Espanol P, Luzarraga A, Teixeira N, Soler C, Luna R, RAMON N. An institutional study: Does Body Mass Index influence surgical approach, surgical morbidities, and outcomes in endometrial cancer patients?. Facts Views And Vision In Obgyn. 2023; 15(3). DOI:10.52054/FVVO.15.3.081. PMID:37742203. IF:1,700 (Q3/6D). Document type: Article.

-Garcia NG, Moreno CS, Teixeira N, Lloret PE, Guibourg R, RAMON N. Comparison of laparoscopy and laparotomy in the management of early-stage ovarian cancer. Gynecology And Minimally Invasive Therapy. 2023; 12(2). DOI:10.4103/gmit.gmit_99_22. PMID:37416098. IF:1,400 (Q3/7D). Document type: Article.

-Habib N, Moufawad G, Hayek J, Futcher F, Chiantera V, RAMON N, Devassy R, Centini G, Mereu L. A Reappraisal of Lymphadenectomy in Common Gynecological Cancers. Clinical and Experimental Obstetrics & Gynecology. 2023; 50(9):181. DOI:10.31083/j.ceog5009181. IF:0,400 (Q4/9D). Document type: Review

-Hernansanz A, RAMON N, Basomba J, Comas R, Casals A. EndoTrainer: a novel hybrid training platform for endoscopic surgery. International Journal of Computer Assisted Radiology and Surgery. 2023; 18(5). DOI:10.1007/s11548-023-02837-x. PMID:36781742. IF:2,300 (Q2/3D). Document type: Article.

-Labidi SI, Rodrigues M, Sandoval JL, Kurtz JE, Heitz F, Mosconi AM, Romero I, Denison U, Nagao S, Vergote I, Parma G, Nøttrup TJ, Rouleau E, Garnier G, El A, Zamagni C, Martín C, Pujade E, Fiévet A, Ray IL. Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis. ANNALS OF ONCOLOGY. 2023; 34(2). DOI:10.1016/j.annonc.2022.11.003. PMID:36564284. IF:56,700 (Q1/1D). Document type: Article

-Pujade E, Brown J, Barnicle A, Wessen J, Lao P, Criscione SW, du A, Lorusso D, Romero I, Petru E, Yoshida H, Vergote I, Colombo N, Hietanen S, Provansal M, Schmalfeldt B, Pignata S, Martín C, Berton D, Runnebaum IB, Ray I. Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus  Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial. JCO Precision Oncology. 2023; 7:e2200258. DOI:10.1200/PO.22.00258. PMID:36716415. IF:5,300 (Q1/2D). Document type: Article.

-Revilla G, Al Qtaish N, Caruana P, Sainz M, Lopez T, Rodriguez F, Paez V, Li CD, Vallverdú NF, Edwards M, Moral A, Pérez JI, Escolà JC, Pedraz JL, Gallego I, Corcoy R, Céspedes MV, Puras G, Mato E. Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior. Biomolecules. 2023; 13(11):1647. DOI:10.3390/biom13111647. PMID:38002329. IF:4,800 (Q1/3D). Document type: Article.

-Rodriguez A, Maroto P, Font A, Martin C, Mellado B, Corbera A, Orrillo M, Reig O, Querol R, Rios A, Cano L, Alonso J, Martinez G, Galtes S, Taus A, Martinez M, Juanpere N, Juan O, Bellmunt J. Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study. BRITISH JOURNAL OF CANCER. 2023; 128(1). DOI:10.1038/s41416-022-01991-4. PMID:36289372. IF:6,400 (Q1/2D). Document type: Article.

-Tarrie JE, Capo JP, Sanchez RM. Update on the possibilities of hormonal medical treatment for heavy menstrual bleeding. CLINICA E INVESTIGACION EN GINECOLOGIA Y OBSTETRICIA. 2023; 50(1). DOI: 10.1016/j.gine.2022.100819. IF:0,100 (Q4/10D). Document type: Review.

(JIF 2022)

• Aznar AL, Lloret PE, Moreno CS, Luna-Guibourg R, Rovira R. Laparoscopic approach for symptomatic pelvic and para-aortic lymphoceles. Journal Of The Turkish-German Gynecological Association. 2022; 23(1). DOI:10.4274/jtgga.galenos.2021.2021.0028. PMID:34109774. Document type: Article.
• Español P, Luna-Guibourg R, Soler-Moreno C, Caruana P, Altes A, Rodriguez F, Porta O, Sanchez O, Llurba E, Rovira R, Cespedes MV. Neural plasticity of the uterus: New targets for endometrial cancer?. Womens Health. 2022; 18:17455057221095537. DOI:10.1177/17455057221095537. PMID:35465787. Document type: Review.
• Fernandez R, Carreno A, Mendoza R, Benito A, Ferrer N, Cespedes MV, Corchero JL. Escherichia coli as a New Platform for the Fast Production of Vault-like Nanoparticles: An Optimized Protocol. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(24):15543. DOI:10.3390/ijms232415543. PMID:36555185. IF:5,6 (Q1/3D). Document type: Article.
• Francis KE, Kim SI, Friedlander M, Gebski V, Ray-Coquard I, Clamp A, Penson RT, Oza A, Perri T, Huzarski T, Martin-Lorente C, Cecere SC, Colombo N, Ataseven B, Fujiwara K, Sonke G, Vergote I, Pujade-Lauraine E, Kim J-W, Lee CK. The impact of olaparib dose reduction and treatment interruption on treatment outcome in the SOLO2/ENGOT-ov21 platinum-sensitive recurrent ovarian cancer. ANNALS OF ONCOLOGY. 2022; 33(6). DOI:10.1016/j.annonc.2022.02.222. PMID:35219776. IF:50,5 (Q1/1D). Document type: Article.
• Lorca C, Laparra M, Cespedes MV, Casani L, Florit S, Jove M, Mota N, Vilella E, Gallart X, Serra A. Industrial By-Products As a Novel Circular Source of Biocompatible Extracellular Vesicles. ADVANCED FUNCTIONAL MATERIALS. 2022; 32(29):2202700. DOI:10.1002/adfm.202202700. IF:19 (Q1/1D). Document type: Article.
• Luzarraga-Aznar A, Teixeira N, Luna-Guibourg R, Español P, Soler-Moreno C, Rovira R. Surgical treatment in older patients with endometrial cancer: A retrospective study. SURGICAL ONCOLOGY-OXFORD. 2022; 44:101852. DOI:10.1016/j.suronc.2022.101852. PMID:36126351. IF:2,3 (Q2/5D). Document type: Article.
• Martin F, Carreno A, Mendoza R, Caruana P, Rodriguez F, Bravo M, Benito A, Ferrer N, Cespedes MV, Corchero JL. All-in-one biofabrication and loading of recombinant vaults in human cells. 2022; 14(2):025018. DOI:10.1088/1758-5090/ac584d. PMID:35203066. IF:9 (Q1/2D). Document type: Article.
• Medina E, Cespedes MV, Gallardo A, Rioja E, Pavon MA, Asensio L, Farre L, Alba L, Unzueta U, Villaverde A, Vazquez E, Casanova I, Mangues R. Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease. 2022; 10(7):1680. DOI:10.3390/biomedicines10071680. PMID:35884987. IF:4,7 (Q1/3D). Document type: Article.
• Rodríguez F, Caruana P, De la Fuente N, Español P, Gámez M, Balart J, Llurba E, Rovira R, Ruiz R, Martín C, Corchero JL, Céspedes MV. Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges. 2022; 12(6):784. DOI:10.3390/biom12060784. PMID:35740909. IF:5,5 (Q1/3D). Document type: Review.
• Sala R, Rioja E, Serna N, Sanchez L, Alamo P, Alba L, Casanova I, Lopez A, Unzueta U, Cespedes MV, Vazquez E, Villaverde A, Mangues R. GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases. DRUG DELIVERY. 2022; 29(1). DOI:10.1080/10717544.2022.2069302. PMID:35532120. IF:6 (Q1/2D). Document type: Article.

• Castro RD, Olloquequi J, Etchetto M, Caruana P, Steele L, Leighton K-M, Ureña J, Beas C, Camins A, Verdaguer E, Auladell C. Dual mkk4 and mkk7 gene deletion in adult mouse causes an impairment of hippocampal immature granule cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021; 22(17):9545. DOI:10.3390/ijms22179545. PMID:34502457. IF:6,208.
• COVIDSurg Collaborative [Sanchez-Lopez A, Balague MC, Targarona E, Sanchez-Cabus S, Molina V, Gonzalez-Lopez JA, Medrano R, Moral A]. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score. BRITISH JOURNAL OF SURGERY. 2021;108(11):1274-1292. DOI:10.1093/bjs/znab183. PMID: 34227657. IF:11,122.
• Iantsen A, Ferreira M, Lucia F, Jaouen V, Reinhold C, Bonaffini P, Alfieri J, RAMON N, Masson I, Robin P, Mervoyer A, Rousseau C, Kridelka F, Decuypere M, Lovinfosse P, Pradier O, Hustinx R, Schick U, Visvikis D, Hatt M. Convolutional neural networks for PET functional volume fully automatic segmentation: development and validation in a multi-center setting. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2021; 48(11). DOI:10.1007/s00259-021-05244-z. PMID:33772335. IF:10,057.
• Luzarraga A, Mora I, Magret E, RAMON N. Laparoscopic Colposacropexy Mesh Excision Secondary to Severe Spondylodiscitis. Journal of Minimally Invasive Gynecology. 2021; 28(11). DOI:10.1016/j.jmig.2021.08.029. PMID:34500066. IF:4,314.
• Redondo A, Guerra E, Manso L, Martin C, Martinez J, Perez JA, Varela MQ, Rubio MJ, Barretina MP, Gonzalez A. SEOM clinical guideline in ovarian cancer (2020). Clinical & Translational Oncology. 2021; 23(5). DOI:10.1007/s12094-020-02545-x. PMID:33515422. IF:3,340.
• Redondo A, Oaknin A, Rubio MJ, Barretina MP, de Juan A, Manso L, Romero I, Martin C, Poveda A, Gonzalez A. Management of advanced ovarian cancer in Spain: an expert Delphi consensus. Journal of Ovarian Research. 2021; 14(1):72. DOI:10.1186/s13048-021-00816-x. PMID:34039386. IF:5,506.
• Tattersall HL, Hodson J, Cardona K, Lee RM, Nessim C, Gladdy R, Van Der Hage J, Schrage Y, Tseng WW, van Houdt W, Novak M, Grignani G, Tolomeo F, Goel N, Ryon E, Gyorki D, Bagaria SP, Gonzalez JA, Arnau ABM, Sayyed R, Tirotta F, Evenden C, Desai A, Almond M, Glasbey J, Fiore M, Gronchi A, Ford SJ. Primary mesenteric sarcomas: Collaborative experience from the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG). JOURNAL OF SURGICAL ONCOLOGY. 2021;123(4):1057-1066. DOI:10.1002/jso.26353. Erratum in: JOURNAL OF SURGICAL ONCOLOGY. 2021;124(3):457. PMID: 33368277. IF:2,885.
• Zapardiel I, Alvarez J, Barahona M, Barri P, Boldo A, Bresco P, Gasca I, Jaunarena I, Kucukmetin A, Mancebo G, Otero B, Roldan F, Rovira R, Suarez E, Tejerizo A, Torrent A, Gorostidi M. Utility of Intraoperative Fluorescence Imaging in Gynecologic Surgery: Systematic Review and Consensus Statement. ANNALS OF SURGICAL ONCOLOGY. 2021;28(6):3266-3278. DOI:10.1245/s10434-020-09222-x. PMID: 33095359. IF:4,339.